|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.48 USD | +14.87% |
|
+7.50% | +58.38% |
| 01-22 | ACM Research, Inc. Updates Revenue Guidance for the Full Year 2025 | CI |
| 01-22 | ACM Research, Inc. Provides Revenue Guidance for the Full Year 2026 | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.81 | 3.47 | 3.23 | 4.39 | 5.64 | |||||
Return on Total Capital | 6.2 | 4.36 | 4.23 | 6.25 | 8.17 | |||||
Return On Equity % | 11.86 | 8.42 | 6.23 | 11.14 | 12.98 | |||||
Return on Common Equity | 15.75 | 9.24 | 5.81 | 10.73 | 12.4 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 44.44 | 44.22 | 47.22 | 49.53 | 50.06 | |||||
SG&A Margin | 18.51 | 16.15 | 16.04 | 15.72 | 17.27 | |||||
EBITDA Margin % | 14.4 | 15.81 | 16.56 | 18.63 | 20.58 | |||||
EBITA Margin % | 13.78 | 14.98 | 15.23 | 17.22 | 19.31 | |||||
EBIT Margin % | 13.72 | 14.9 | 15.18 | 17.18 | 19.31 | |||||
Income From Continuing Operations Margin % | 13.84 | 16.52 | 13 | 17.37 | 16.78 | |||||
Net Income Margin % | 11.99 | 14.54 | 10.1 | 13.87 | 13.25 | |||||
Net Avail. For Common Margin % | 11.99 | 14.54 | 10.1 | 13.87 | 13.25 | |||||
Normalized Net Income Margin | 0.83 | 8.23 | 9 | 8.82 | 9.53 | |||||
Levered Free Cash Flow Margin | -13.5 | -23.24 | -41.91 | -20.52 | 2.6 | |||||
Unlevered Free Cash Flow Margin | -13.11 | -23.06 | -41.64 | -20.22 | 2.93 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.56 | 0.37 | 0.34 | 0.41 | 0.47 | |||||
Fixed Assets Turnover | 15.67 | 16.91 | 7.51 | 3.79 | 3.13 | |||||
Receivables Turnover (Average Receivables) | 3.58 | 3.21 | 2.7 | 2.39 | 2.33 | |||||
Inventory Turnover (Average Inventory) | 1.3 | 0.94 | 0.67 | 0.6 | 0.68 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.53 | 4.63 | 2.43 | 2.35 | 2.31 | |||||
Quick Ratio | 1.61 | 3.49 | 1.39 | 1.21 | 1.36 | |||||
Operating Cash Flow to Current Liabilities | -0.13 | -0.19 | -0.16 | -0.15 | 0.24 | |||||
Days Sales Outstanding (Average Receivables) | 102.27 | 113.82 | 135.4 | 152.53 | 156.82 | |||||
Days Outstanding Inventory (Average Inventory) | 280.59 | 386.37 | 543.62 | 608.47 | 535.73 | |||||
Average Days Payable Outstanding | 68.33 | 91.09 | 104.41 | 113.36 | 127.46 | |||||
Cash Conversion Cycle (Average Days) | 314.53 | 409.09 | 574.62 | 647.63 | 565.1 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 24.03 | 4.82 | 9.79 | 10.7 | 17.23 | |||||
Total Debt / Total Capital | 19.37 | 4.6 | 8.92 | 9.67 | 14.69 | |||||
LT Debt/Equity | 10.02 | 3.06 | 2.44 | 6.29 | 9.98 | |||||
Long-Term Debt / Total Capital | 8.08 | 2.92 | 2.22 | 5.68 | 8.51 | |||||
Total Liabilities / Total Assets | 39 | 22.86 | 34.26 | 37.88 | 40.94 | |||||
EBIT / Interest Expense | 21.89 | 50.59 | 35.67 | 35.75 | 36.38 | |||||
EBITDA / Interest Expense | 24.87 | 57.78 | 41.2 | 40.51 | 40.13 | |||||
(EBITDA - Capex) / Interest Expense | -21.38 | 45.81 | -13.84 | 17.43 | 20.26 | |||||
Total Debt / EBITDA | 2.05 | 0.89 | 1.17 | 0.91 | 1.13 | |||||
Net Debt / EBITDA | -2.05 | -12.52 | -3.8 | -1.7 | -1.53 | |||||
Total Debt / (EBITDA - Capex) | -2.38 | 1.12 | -3.47 | 2.12 | 2.24 | |||||
Net Debt / (EBITDA - Capex) | 2.38 | -15.79 | 11.32 | -3.95 | -3.04 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 45.66 | 65.84 | 49.69 | 43.44 | 40.23 | |||||
Gross Profit, 1 Yr. Growth % | 37.4 | 65.03 | 59.87 | 50.43 | 41.76 | |||||
EBITDA, 1 Yr. Growth % | 21.36 | 82.09 | 56.87 | 61.38 | 54.88 | |||||
EBITA, 1 Yr. Growth % | 21.35 | 80.18 | 52.24 | 62.13 | 57.55 | |||||
EBIT, 1 Yr. Growth % | 20.8 | 80.08 | 52.54 | 62.34 | 57.55 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 11.4 | 98 | 17.81 | 91.54 | 35.54 | |||||
Net Income, 1 Yr. Growth % | -0.6 | 101.05 | 3.99 | 97 | 33.97 | |||||
Normalized Net Income, 1 Yr. Growth % | -88.44 | 1.54K | 63.87 | 40.49 | 51.6 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -10.09 | 94.15 | 2.76 | 96.64 | 31.52 | |||||
Accounts Receivable, 1 Yr. Growth % | 81.53 | 87.01 | 73.31 | 54.8 | 36.68 | |||||
Inventory, 1 Yr. Growth % | 97.87 | 146.07 | 80.26 | 38.72 | 9.64 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 66.39 | 45.92 | 368.42 | 144.69 | 30.41 | |||||
Total Assets, 1 Yr. Growth % | 56.75 | 208.32 | 17.42 | 20.67 | 24.47 | |||||
Tangible Book Value, 1 Yr. Growth % | 35.03 | 408.64 | -0.17 | 13.77 | 17.82 | |||||
Common Equity, 1 Yr. Growth % | 45.04 | 379.07 | -0.2 | 13.71 | 17.88 | |||||
Cash From Operations, 1 Yr. Growth % | -244.07 | 195.95 | 55.12 | 21.11 | -302.4 | |||||
Capital Expenditures, 1 Yr. Growth % | 4.58K | -79.85 | 895.24 | -32.07 | 33.27 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -62.01 | 185.6 | 167.58 | -29.77 | -117.75 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -62.8 | 191.81 | 167.99 | -30.35 | -120.31 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 44.86 | 55.43 | 57.56 | 46.53 | 41.83 | |||||
Gross Profit, 2 Yr. CAGR % | 42.14 | 50.58 | 62.42 | 55.08 | 46.03 | |||||
EBITDA, 2 Yr. CAGR % | 80.92 | 48.65 | 69.01 | 59.11 | 58.1 | |||||
EBITA, 2 Yr. CAGR % | 82.66 | 47.87 | 66 | 57.11 | 59.93 | |||||
EBIT, 2 Yr. CAGR % | 82.24 | 47.49 | 65.74 | 57.36 | 59.93 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 81.59 | 48.52 | 52.73 | 50.22 | 61.12 | |||||
Net Income, 2 Yr. CAGR % | 69.02 | 41.36 | 44.59 | 43.13 | 62.46 | |||||
Normalized Net Income, 2 Yr. CAGR % | -46.84 | 37.67 | 418.24 | 51.73 | 45.94 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 55.12 | 32.12 | 40.47 | 42.15 | 60.81 | |||||
Accounts Receivable, 2 Yr. CAGR % | 51.45 | 84.25 | 80.03 | 63.8 | 45.46 | |||||
Inventory, 2 Yr. CAGR % | 51.22 | 120.66 | 110.61 | 58.13 | 23.33 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 83.52 | 55.82 | 161.44 | 238.55 | 82.18 | |||||
Total Assets, 2 Yr. CAGR % | 81.98 | 119.84 | 90.27 | 19.04 | 22.56 | |||||
Tangible Book Value, 2 Yr. CAGR % | 58.61 | 162.07 | 125.33 | 6.57 | 16.42 | |||||
Common Equity, 2 Yr. CAGR % | 64.24 | 163.59 | 118.66 | 6.53 | 15.78 | |||||
Cash From Operations, 2 Yr. CAGR % | 40.03 | 106.49 | 114.27 | 37.07 | 56.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | 398.18 | 207.02 | 41.62 | 160 | -4.86 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 248.35 | 4.17 | 177.63 | 37.09 | -64.69 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 216.17 | 4.19 | 180.86 | 36.62 | -62.39 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 62.49 | 51.54 | 53.49 | 52.7 | 44.4 | |||||
Gross Profit, 3 Yr. CAGR % | 59.28 | 49.39 | 53.61 | 58.32 | 50.5 | |||||
EBITDA, 3 Yr. CAGR % | 188.09 | 81.31 | 51.34 | 66.43 | 57.68 | |||||
EBITA, 3 Yr. CAGR % | 213.61 | 81.83 | 49.31 | 64.7 | 57.16 | |||||
EBIT, 3 Yr. CAGR % | 213.13 | 81.52 | 49.15 | 64.6 | 57.43 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 191.85 | 86.9 | 37.48 | 64.7 | 45.15 | |||||
Net Income, 3 Yr. CAGR % | 289.42 | 79.08 | 27.61 | 60.29 | 40.01 | |||||
Normalized Net Income, 3 Yr. CAGR % | 54.88 | 66.7 | 45.9 | 235.4 | 51.69 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 160.94 | 67.17 | 21.5 | 57.14 | 38.51 | |||||
Accounts Receivable, 3 Yr. CAGR % | 28.24 | 62.48 | 80.53 | 71.2 | 54.2 | |||||
Inventory, 3 Yr. CAGR % | 79.26 | 77.86 | 106.28 | 83.24 | 39.96 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 74.76 | 70.02 | 124.88 | 155.73 | 149.58 | |||||
Total Assets, 3 Yr. CAGR % | 71.3 | 116.95 | 78.37 | 63.48 | 20.82 | |||||
Tangible Book Value, 3 Yr. CAGR % | 48.79 | 133.9 | 89.98 | 79.43 | 10.6 | |||||
Common Equity, 3 Yr. CAGR % | 52.43 | 134.67 | 90.69 | 75.84 | 10.19 | |||||
Cash From Operations, 3 Yr. CAGR % | 18.7 | 79.7 | 87.71 | 77.16 | 56.08 | |||||
Capital Expenditures, 3 Yr. CAGR % | 311.67 | 71.02 | 354.38 | 10.86 | 108.08 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 34.55 | 226.04 | 43.07 | 75.59 | -30.65 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 34.13 | 207.83 | 43.17 | 76.45 | -27.62 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 38.08 | 56.84 | 60.5 | 49.52 | 48.71 | |||||
Gross Profit, 5 Yr. CAGR % | 37.58 | 53.84 | 60.53 | 51.64 | 50.53 | |||||
EBITDA, 5 Yr. CAGR % | 35.14 | 62.08 | 132.74 | 72.08 | 54.01 | |||||
EBITA, 5 Yr. CAGR % | 34.73 | 61.97 | 142.93 | 71.51 | 53.37 | |||||
EBIT, 5 Yr. CAGR % | 34.61 | 61.8 | 142.77 | 71.44 | 53.37 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.32 | 78.22 | 125.25 | 71.26 | 46.49 | |||||
Net Income, 5 Yr. CAGR % | 28.41 | 105.47 | 162.01 | 63.73 | 40.55 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.35 | 111.26 | 151.08 | 60.54 | 45.92 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.7 | 57.2 | 104.14 | 56.67 | 35.92 | |||||
Accounts Receivable, 5 Yr. CAGR % | 36.14 | 45.79 | 46.88 | 63 | 65.59 | |||||
Inventory, 5 Yr. CAGR % | 57.5 | 79.62 | 91.2 | 69.69 | 67.92 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 47.81 | 51.79 | 105.31 | 123.95 | 106.71 | |||||
Total Assets, 5 Yr. CAGR % | 60.39 | 88.28 | 78.65 | 70.64 | 53.51 | |||||
Tangible Book Value, 5 Yr. CAGR % | 73.89 | 206.78 | 75.66 | 70.8 | 56.18 | |||||
Common Equity, 5 Yr. CAGR % | 76.52 | 208.14 | 76.09 | 71.11 | 56.19 | |||||
Cash From Operations, 5 Yr. CAGR % | 38.05 | 61.04 | 50.33 | 61.25 | 74.57 | |||||
Capital Expenditures, 5 Yr. CAGR % | 101.39 | 63.02 | 168.65 | 102.22 | 143.11 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | 72.55 | 79.77 | 130.94 | -18.25 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | 73.28 | 80.26 | 122.81 | -16.12 |
- Stock Market
- Equities
- ACMR Stock
- Financials ACM Research, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















